The FDA turned down Abbott -- maker of Synthroid -- in their attempt to block the approval of generic levothyroxines. This refusal paved the way for various manufacturers to release generic versions of Synthroid and Levoxyl. This year, three new levothyroxines hit the market. Find out more about what this means for you as a consumer, and things to watch out for in with this major development.


